FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059170306> ?p ?o ?g. }

• W2059170306 endingPage "265" @default.
• W2059170306 startingPage "250" @default.
• W2059170306 abstract "The University of Pittsburgh Molecular Library Screening Center (Pittsburgh, PA) conducted a screen with the National Institutes of Health compound library for inhibitors of in vitro cell division cycle 25 protein (Cdc25) B activity during the pilot phase of the Molecular Library Screening Center Network. Seventy-nine (0.12%) of the 65,239 compounds screened at 10 muM met the active criterion of > or =50% inhibition of Cdc25B activity, and 25 (31.6%) of these were confirmed as Cdc25B inhibitors with 50% inhibitory concentration (IC(50)) values <50 microM. Thirteen of the Cdc25B inhibitors were represented by singleton chemical structures, and 12 were divided among four clusters of related structures. Thirteen (52%) of the Cdc25B inhibitor hits were quinone-based structures. The Cdc25B inhibitors were further characterized in a series of in vitro secondary assays to confirm their activity, to determine their phosphatase selectivity against two other dual-specificity phosphatases, mitogen-activated protein kinase phosphatase (MKP)-1 and MKP-3, and to examine if the mechanism of Cdc25B inhibition involved oxidation and inactivation. Nine Cdc25B inhibitors did not appear to affect Cdc25B through a mechanism involving oxidation because they did not generate detectable amounts of H(2)O(2) in the presence of dithiothreitol, and their Cdc25B IC(50) values were not significantly affected by exchanging the dithiothreitol for beta-mercaptoethanol or reduced glutathione or by adding catalase to the assay. Six of the nonoxidative hits were selective for Cdc25B inhibition versus MKP-1 and MKP-3, but only the two bisfuran-containing hits, PubChem substance identifiers 4258795 and 4260465, significantly inhibited the growth of human MBA-MD-435 breast and PC-3 prostate cancer cell lines. To confirm the structure and biological activity of 4260465, the compound was resynthesized along with two analogs. Neither of the substitutions to the two analogs was tolerated, and only the resynthesized hit 26683752 inhibited Cdc25B activity in vitro (IC(50) = 13.83 +/- 1.0 microM) and significantly inhibited the growth of the MBA-MD-435 breast and PC-3 prostate cancer cell lines (IC(50) = 20.16 +/- 2.0 microM and 24.87 +/- 2.25 microM, respectively). The two bis-furan-containing hits identified in the screen represent novel nonoxidative Cdc25B inhibitor chemotypes that block tumor cell proliferation. The availability of non-redox active Cdc25B inhibitors should provide valuable tools to explore the inhibition of the Cdc25 phosphatases as potential mono- or combination therapies for cancer." @default.
• W2059170306 created "2016-06-24" @default.
• W2059170306 creator A5018024103 @default.
• W2059170306 creator A5029471010 @default.
• W2059170306 creator A5056286543 @default.
• W2059170306 creator A5060182773 @default.
• W2059170306 creator A5062540982 @default.
• W2059170306 creator A5070043526 @default.
• W2059170306 creator A5085858115 @default.
• W2059170306 creator A5087599491 @default.
• W2059170306 creator A5089450675 @default.
• W2059170306 date "2009-06-01" @default.
• W2059170306 modified "2023-10-14" @default.
• W2059170306 title "Cdc25B Dual-Specificity Phosphatase Inhibitors Identified in a High-Throughput Screen of the NIH Compound Library" @default.
• W2059170306 cites W1640748652 @default.
• W2059170306 cites W1921965616 @default.
• W2059170306 cites W1963977723 @default.
• W2059170306 cites W1967157579 @default.
• W2059170306 cites W1972684496 @default.
• W2059170306 cites W1974091790 @default.
• W2059170306 cites W1978387073 @default.
• W2059170306 cites W1979657965 @default.
• W2059170306 cites W1982629919 @default.
• W2059170306 cites W1985776151 @default.
• W2059170306 cites W1991001144 @default.
• W2059170306 cites W2000897097 @default.
• W2059170306 cites W2024540523 @default.
• W2059170306 cites W2029935944 @default.
• W2059170306 cites W2030381529 @default.
• W2059170306 cites W2031360163 @default.
• W2059170306 cites W2034567120 @default.
• W2059170306 cites W2037813091 @default.
• W2059170306 cites W2038907204 @default.
• W2059170306 cites W2043617798 @default.
• W2059170306 cites W2043624162 @default.
• W2059170306 cites W2045166000 @default.
• W2059170306 cites W2047272425 @default.
• W2059170306 cites W2052643283 @default.
• W2059170306 cites W2052648700 @default.
• W2059170306 cites W2057124829 @default.
• W2059170306 cites W2061322294 @default.
• W2059170306 cites W2062219923 @default.
• W2059170306 cites W2067138633 @default.
• W2059170306 cites W2068235622 @default.
• W2059170306 cites W2085664820 @default.
• W2059170306 cites W2089473708 @default.
• W2059170306 cites W2102258234 @default.
• W2059170306 cites W2105772745 @default.
• W2059170306 cites W2107235167 @default.
• W2059170306 cites W2109734459 @default.
• W2059170306 cites W2125325561 @default.
• W2059170306 cites W2128879247 @default.
• W2059170306 cites W2142981438 @default.
• W2059170306 cites W2153891907 @default.
• W2059170306 cites W2154431772 @default.
• W2059170306 cites W2156761524 @default.
• W2059170306 cites W2159042032 @default.
• W2059170306 cites W2165443290 @default.
• W2059170306 cites W2166056968 @default.
• W2059170306 cites W2171802580 @default.
• W2059170306 cites W2341672826 @default.
• W2059170306 cites W2952781201 @default.
• W2059170306 doi "https://doi.org/10.1089/adt.2008.186" @default.
• W2059170306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2956648" @default.
• W2059170306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19530895" @default.
• W2059170306 hasPublicationYear "2009" @default.
• W2059170306 type Work @default.
• W2059170306 sameAs 2059170306 @default.
• W2059170306 citedByCount "32" @default.
• W2059170306 countsByYear W20591703062012 @default.
• W2059170306 countsByYear W20591703062013 @default.
• W2059170306 countsByYear W20591703062014 @default.
• W2059170306 countsByYear W20591703062015 @default.
• W2059170306 countsByYear W20591703062016 @default.
• W2059170306 countsByYear W20591703062017 @default.
• W2059170306 countsByYear W20591703062018 @default.
• W2059170306 countsByYear W20591703062019 @default.
• W2059170306 countsByYear W20591703062021 @default.
• W2059170306 countsByYear W20591703062022 @default.
• W2059170306 countsByYear W20591703062023 @default.
• W2059170306 crossrefType "journal-article" @default.
• W2059170306 hasAuthorship W2059170306A5018024103 @default.
• W2059170306 hasAuthorship W2059170306A5029471010 @default.
• W2059170306 hasAuthorship W2059170306A5056286543 @default.
• W2059170306 hasAuthorship W2059170306A5060182773 @default.
• W2059170306 hasAuthorship W2059170306A5062540982 @default.
• W2059170306 hasAuthorship W2059170306A5070043526 @default.
• W2059170306 hasAuthorship W2059170306A5085858115 @default.
• W2059170306 hasAuthorship W2059170306A5087599491 @default.
• W2059170306 hasAuthorship W2059170306A5089450675 @default.
• W2059170306 hasBestOaLocation W20591703062 @default.
• W2059170306 hasConcept C120504264 @default.
• W2059170306 hasConcept C1491633281 @default.
• W2059170306 hasConcept C158180186 @default.
• W2059170306 hasConcept C178666793 @default.
• W2059170306 hasConcept C181199279 @default.
• W2059170306 hasConcept C184235292 @default.
• W2059170306 hasConcept C185592680 @default.

• next